Summit Securities Group’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	–	–	727
2023 Q3	–	Hold	0	–	–	–	867